Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M
U.S. health agencies participated in WHO flu meeting despite planned exit
Teva targets schizophrenia to build on innovative medicines growth
*please scroll down for all the latest news*
